NewsGlobeNewswire
MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study
· Published
Article summary
MIRA-55 demonstrated significant pain relief comparable to Celebrex in a 21-day preclinical study of chronic inflammatory pain.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…